Medicamen Biotech Limited — Others, 06-12-2024: Price movement

Medicamen Biotech has responded to the National Stock Exchange's inquiry regarding recent significant share price movements, stating that there are no reportable events affecting the company's operations or performance. The management clarified that the share price increase is market-driven and not influenced by any company-related information. The company emphasized its adherence to disclosure requirements and will continue to provide updates as necessary. For investors, this suggests a neutral impact, as the price shift appears unrelated to any operational developments. Overall, it reinforces transparency amid market fluctuations.